Penumbra, Inc. logo PEN - Penumbra, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 9
HOLD 13
SELL 0
STRONG
SELL
0
| PRICE TARGET: $320.00 DETAILS
HIGH: $320.00
LOW: $320.00
MEDIAN: $320.00
CONSENSUS: $320.00
DOWNSIDE: 0.67%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 85% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 100.7% above fair value
Current Price $322.17
Bear Case $91.77 71.5% downside ($91.77 - $322.17) / $322.17 = -71.5% 12% stage 1 growth, 11% discount
Fair Value $160.52 50.2% downside ($160.52 - $322.17) / $322.17 = -50.2% 20% stage 1 growth, 11% discount
Bull Case $246.76 23.4% downside ($246.76 - $322.17) / $322.17 = -23.4% 26% stage 1 growth, 11% discount

Adjust Assumptions

19.9%
11.0%
3.0%

Key Value Driver

FCF growth rate (20% base case)

Terminal Value % of EV 46%
Implied Market Multiple 93.9x
Market is pricing in (growth) 29.6% vs our 20.0% base

Plain-Language Summary

Using a two-stage FCF DCF with 20% growth decelerating over 15 years, discounted at 11%, the base-case intrinsic value is $160.52 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (22 analysts) $320.00
Analyst Range $320.00 – $320.00
Divergence from AlphaVal 50%

Warnings

Stock-based employee pay equals 33% of profits. This dilutes existing shareholders, so cash flow alone overstates what owners really earn.
Wall Street's average price target is $320.00 (from 22 analysts). Our estimate is 50% below the consensus -- consider that gap carefully.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions